Randomized double-blinded, placebo-controlled, cross-over trial of allopurinol for the treatment of post-renal-transplant hypertension in children
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Allopurinol (Primary)
- Indications Renal hypertension
- Focus Therapeutic Use
- 13 Sep 2017 Biomarkers information updated
- 06 Aug 2008 Patient numbers changed from 25 to 0 as reported by ClinicalTrials.gov.
- 06 Aug 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.